Persisting risk factors for preeclampsia among high-risk pregnancies already using prophylactic aspirin: a multi-country retrospective investigation

Katherine A. Muldoon, Cheynne McLean, Darine El‐Chaâr, Daniel J. Corsi, Natalie Rybak, Amarjargal Dagvadorj, Yanfang Guo, Ruth Rennicks White, Alysha L. J. Dingwall‐Harvey, Laura Gaudet,

The Journal of Maternal-Fetal & Neonatal Medicine · 2023 · 11 citations · 18 references

DOIFull text

Open access

Abstract

These findings suggest that individuals with twin pregnancies, a history of preeclampsia, or hypertension may not benefit from aspirin to the same extent as those with other complications such as obesity or diabetes. Careful clinical monitoring for these risks factors is recommended and future research into the effectiveness in these populations would increase our understanding of the current best practice of prophylactic aspirin use to prevent preeclampsia. <b>TRIAL REGISTRATION:</b> Current Controlled Trials ISRCTN23781770 and ClinicalTrials.gov NCT01355159.

References

18